Dl-Phenylalanine

Dl-Phenylalanine

SCHEMBL464776

CSCCC(N)C(=O)O.NC(Cc1ccccc1)C(=O)O

nearest known ligand 0.69

Full drug profile on Sugi Atlas →

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
SLC7A5 Q01650 2/20 0.69
ALPI P09923 1/20 0.69
PKM P14618 1/20 0.69
PTGS1 P23219 1/20 0.69
XIAP P98170 1/20 0.69
SLC1A3 P43003 1/20 0.51
SLC1A2 P43004 1/20 0.51
SLC1A1 P43005 1/20 0.51
KMT2A Q03164 1/20 0.48
NOS3 P29474 2/20 0.48
NOS1 P29475 2/20 0.48
NOS2 P35228 2/20 0.48
SLC15A1 P46059 1/20 0.47
FNTA P49354 3/20 0.47
FNTB P49356 3/20 0.47
PGGT1B P53609 3/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Phenylalanine SCHEMBL28231547 1.00 SLC7A5 (0.69) SLC7A5ALPIPKMPTGS1XIAP
Dl-Phenylalanine SCHEMBL29503517 1.00 SLC7A5 (0.69) SLC7A5ALPIPKMPTGS1XIAP
Phenylalanine SCHEMBL464777 1.00 SLC7A5 (0.69) SLC7A5ALPIPKMPTGS1XIAP
Dl-Phenylalanine SCHEMBL28076342 1.00 SLC7A5 (0.69) SLC7A5ALPIPKMPTGS1XIAP
Dl-Phenylalanine SCHEMBL23924471 0.94 SLC7A5 (0.61) SLC7A5ALPIPKMPTGS1XIAP
Phenylalanine SCHEMBL6753059 0.94 SLC7A5 (0.61) SLC7A5ALPIPKMPTGS1XIAP
Phenylalanine SCHEMBL6276488 0.94 SLC7A5 (0.61) SLC7A5ALPIPKMPTGS1XIAP
Phenylalanine SCHEMBL7089920 0.94 SLC7A5 (0.61) SLC7A5ALPIPKMPTGS1XIAP
Phenylalanine SCHEMBL10775098 0.93 SLC7A5 (0.59) SLC7A5ALPIPKMPTGS1XIAP
Dl-Phenylalanine SCHEMBL22500849 0.93 SLC7A5 (0.59) SLC7A5ALPIPKMPTGS1XIAP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 87 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116209669-A Cationic steroidal antimicrobial compounds with endogenous groups 布莱阿姆青年大学 2023-06-02 CN claimed
CN-108135903-A PSMA-targeted NIR dyes and uses thereof 目标实验室有限责任公司 2018-06-08 CN claimed
EP-3277098-A1 NOVEL AND USEFUL EDIBLE SALT AND METHODS OF USE AND PRODUCTION THEREOF E.k.salt Ltd. (IL) 2018-02-07 EP claimed
WO-2016157178-A1 NOVEL AND USEFUL EDIBLE SALT AND METHODS OF USE AND PRODUCTION THEREOF E.K.SALT LTD. (IL) 2016-10-06 WO claimed
US-9181224-B2 Bifunctional molecules with antibody-recruiting and entry inhibitory activity against the human immunodeficiency virus YALE UNIVERSITY (US) 2015-11-10 US claimed
CN-103998449-A Pyrrolobenzodiazepines SPIROGEN LTD 2014-08-20 CN claimed
CN-103998450-A Pyrrolobenzodiazepines SPIROGEN SARL 2014-08-20 CN claimed
CN-103987718-A Pyrrolobenzodiazepines as unsymmetrical dimeric PBD compounds for inclusion in targeted conjugates SPIROGEN SARL 2014-08-13 CN claimed
CN-102971329-A Pyrrolobenzodiazepines for the treatment of proliferative diseases SPIROGEN LTD 2013-03-13 CN claimed
WO-2006031844-A2 TREATING THE CAUSE OF BACK PAIN WITH TRACTION WITHIN HYPERBARIC CHAMBER YEUNG JEFFREY E (US) 2006-03-23 WO claimed
EP-1383793-A2 INSULIN AND IGF-1 RECEPTOR AGONISTS AND ANTAGONISTS DGI BioTechnologies, L.L.C. (US) 2004-01-28 EP claimed
WO-2001072771-A2 INSULIN AND IGF-1 RECEPTOR AGONISTS AND ANTAGONISTS DGI BIOTECHNOLOGIES, L.L.C. (US) 2001-10-04 WO claimed
US-5304658-A Quinone derivatives, their production and use TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1994-04-19 US claimed
CN-115427437-A Novel immunologically active interleukin-2 analogs 韩美药品株式会社 2022-12-02 CN disclosed
CN-115052619-A Pharmaceutical composition for preventing or treating metabolic bone disease comprising GLP-2 or conjugate thereof 韩美药品株式会社 2022-09-13 CN disclosed
CN-114786706-A Glucagon, compositions comprising dual agonists of the GLP-1 receptor and the GIP receptor, and therapeutic uses thereof 韩美药品株式会社 2022-07-22 CN disclosed
CN-1181399-A Bleed alleviation in ink jet inks using acids containing basic functional group HEWLETT PACKARD CO (US) 1998-05-13 CN disclosed
EP-0763107-A1 PANTROPIC NEUROTROPHIC FACTORS GENENTECH, INC. (US) 1997-03-19 EP disclosed
WO-1995033829-A1 PANTROPIC NEUROTROPHIC FACTORS GENENTECH, INC. (US) 1995-12-14 WO disclosed
US-4604286-A Infusion solution for parenteral nutrition DAIGO NUTRITIVE CHEMICALS, LTD. (JP) 1986-08-05 US disclosed